January 08, 2025

Calcium Cuts Colorectal Cancer Risk by 17%, Large Study Finds

Calcium intake reduces colorectal cancer risk by 17% per 300 mg/day, with dairy sources showing the strongest associations, as revealed in a large-scale study.

Conexiant

December 26, 2024

Advancing Small-Cell Lung Cancer Care with Molecular Subtyping

Study of 195 SCLC patients emphasizes the diagnostic and therapeutic potential of 4 molecular subtypes and associated biomarkers.

Conexiant

December 20, 2024

Riluzole Shows Promise in Reversing Cognitive Decline from Radiation Therapy

Boosting brain-derived neurotrophic factor (BDNF) with riluzole may mitigate cognitive dysfunction from radiation therapy.

Conexiant

December 18, 2024

Understanding the 2022 WHO Classification of Endocrine Tumors

From the parathyroid to adrenal glands and thyroid tumors, the latest WHO classification introduces essential updates to tumor nomenclature and diagnostic criteria.

Conexiant

December 13, 2024

MTAP Deficiency: A New Biomarker and Therapeutic Target in Aggressive Urothelial Bladder Cancer

With MTAP loss predictive of worse outcomes, researchers explore precision therapies and diagnostic advancements in bladder cancer.

Conexiant

September 30, 2024

New DNA Test Accurately Differentiates Between Thymic Tumors

Misdiagnosis can lead to inappropriate treatment, potentially subjecting patients to unnecessary toxicity or, conversely, inadequate treatment for a life-threatening cancer.

Conexiant

September 26, 2024

T Cell Spatial Patterns Linked to CRC Survival

Study links shorter T-cell proximity to cancer cells with improved survival rates in colorectal cancer.

Conexiant

September 26, 2024

Breast Cancer Diagnosis: 55% Gain in Efficiency With AI-Assisted Pathology

AI technology aids pathologists in improving diagnostic speed and accuracy in the challenging task of detecting breast cancer metastases in lymph nodes.

Conexiant

October 02, 2024

MicroRNA Regulation Linked to Aggressive Prostate Cancer in Hypoxic Tumor

Understanding how prostate cancer cells adapt to hypoxia through microRNA regulation may unlock new approaches for fighting aggressive cancer.

Conexiant